David N Huynh

EP 80317, a selective CD36 ligand, shows cardioprotective effects against post-ischaemic myocardial damage in mice.

Roger Lecomte, Brigitte Guérin, M. Bentourkia, 2012, Cardiovascular research.

EX VIVO IKKβ ABLATION RESCUES THE IMMUNOPOTENCY OF MESENCHYMAL STROMAL CELLS FROM DIABETICS WITH ADVANCED ATHEROSCLEROSIS.

D. Shum-Tim, M. Servant, H. Ong, 2020, Cardiovascular research.

Potential peptides in atherosclerosis therapy.

H. Ong, S. Marleau, David N Huynh, 2014, Frontiers of hormone research.

Oxidative stress-induced senescence mediates inflammatory and fibrotic phenotypes in fibroblasts from systemic sclerosis patients.

M. Baron, G. Ferbeyre, Mariana Acevedo, 2021, Rheumatology.

Optimization of a Liposomal DNase I Formulation with an Extended Circulating Half-Life.

D. Brambilla, S. Marleau, David N Huynh, 2022, Molecular pharmaceutics.

Cooperative role of endogenous leucotrienes and platelet-activating factor in ischaemia–reperfusion-mediated tissue injury

L. Faccioli, Tania Lévesque, S. Marleau, 2013, Journal of cellular and molecular medicine.

A Linear Fragment of Unacylated Ghrelin (UAG6−13) Protects Against Myocardial Ischemia/Reperfusion Injury in Mice in a Growth Hormone Secretagogue Receptor-Independent Manner

A. Carpentier, R. Granata, Y. Burelle, 2019, Front. Endocrinol..

Adiponectin has a pivotal role in the cardioprotective effect of CP‐3(iv), a selective CD36 azapeptide ligand, after transient coronary artery occlusion in mice

A. Carpentier, M. Febbraio, W. Lubell, 2017, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

A cyclic azapeptide ligand of the scavenger receptor CD36/SR-B2 reduces the atherosclerotic lesion progression and enhances plaque stability in apolipoprotein E-deficient mice

W. Lubell, H. Ong, S. Marleau, 2023, Frontiers in Pharmacology.

EP 80317, a selective CD36 ligand, shows cardioprotective effects against post-ischaemic myocardial damage in mice.

M. Bentourkia, R. Lecomte, A. Carpentier, 2012, Cardiovascular Research.

Pharmacological targeting of the hyper-inflammatory response to SARS-CoV-2-infected K18-hACE2 mice using a cluster of differentiation 36 receptor modulator

W. Lubell, H. Ong, S. Marleau, 2024, Frontiers in pharmacology.